Moderna Inc

Is It Time For Moderna To Boost Share Buyback And Start Paying Dividends?

Equity Bottom-Up
265 Views, 20 Jan 2022 23:30
Andrei has highlighted this Insight as a Top Pick
  • Shares of Moderna Inc (MRNA US) underperformed and fell ~32% YTD. Investors continued to cut exposure to stocks of COVID vaccine makers, including BioNTech, Novavax, CureVac, among others.
  • In August 2021, Moderna announced the first share buyback plan. The company’s Board of Directors has authorized share repurchase for up to $1 billion with an expiry date in 2023. 
  • We estimate Moderna may end 2021 with a total of ~$18.5 billion in cash, cash eq., investments and expect the company may boost share buyback in the future.
detail (4-minute read)
Andrei Zakharov
Director of Equity Research, IPOs
Algosun Global
Information Technology & EnergyEquitiesEquity Capital MarketsThematic (Sector/Industry)

A highly collaborative entrepreneurial Founder and Director of Algosun Global Limited with broad professional experience...